Cargando…
Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?
BACKGROUND: Introduction of the 7-valent pneumococcal conjugate vaccine (7vCRM) in several countries has led to a rapid, significant drop in vaccine-type invasive pneumococcal disease (IPD) in immunized children. In the United States and some other countries with high antibiotic use, a subsequent ri...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829470/ https://www.ncbi.nlm.nih.gov/pubmed/20122261 http://dx.doi.org/10.1186/1471-2431-10-4 |